# Charles Lu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/charles-lu-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,384 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 45 |
| i10-index | 87 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5103196172 |
| ORCID iD | https://orcid.org/0000-0002-3392-6024 |
| Works | 241 |

## Researcher papers

- [Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer](https://scholariq.org/papers/human-papillomavirus-and-survival-of-patients-with-oropharyngeal-cancer/)
- [Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial](https://scholariq.org/papers/neoadjuvant-nivolumab-or-nivolumab-plus-ipilimumab-in-operable-non-small-cell/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Nonmelanoma Skin Cancer Studies](https://scholariq.org/topics/nonmelanoma-skin-cancer-studies/)
- [Salivary Gland Tumors Diagnosis and Treatment](https://scholariq.org/topics/salivary-gland-tumors-diagnosis-and-treatment/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.